Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manganese Primed Anti-PD-1 and Chemotherapy in Pancreatic Cancer
NCT03989310Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Mar 2019
- Primary completion
- May 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of manganese chloride in pancreatic cancer (PC), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
manganese chloride
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03989310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03989310.